Editorial: Red wine coming up roses for intestinal ischemia reperfusion injury: Role for resveratrol?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 11, 2009, Pages 1703-1705

  Ajamieh, Hussam ^a   Teoh, Narci C ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; GLUTATHIONE; LACTATE DEHYDROGENASE; LIPID PEROXIDE; MALONALDEHYDE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; ANTIOXIDANT; STILBENE DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; INTESTINE ISCHEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RED WINE; REPERFUSION INJURY; ANIMAL; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; HUMAN; LIVER; METABOLISM; NOTE; PATHOLOGY; RAT; SMALL INTESTINE; VASCULARIZATION; WINE;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; HUMANS; INTESTINE, SMALL; LIVER; OXIDATIVE STRESS; RATS; REPERFUSION INJURY; STILBENES; WINE;

EID: 70449411771     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06014.x     Document Type: Editorial

References (15)

1. Frishman WH, Novak S, Brandt LJ et al. Pharmacologic management of mesenteric occlusive disease. Cardiol. Rev. 2008 16 : 59 68.
2. Cerqueira NF, Hussni CA, Yoshida WB. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir. Bras. 2005 20 : 336 343.
3. Stallion A, Kou TD, Latifi SQ et al. Ischemia/reperfusion: a clinically relevant model of intestinal injury yielding systemic inflammation. J. Pediatr. Surg. 2005 40 : 470 477.
4. Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev. 2006 58 : 87 114.
5. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006 5 : 493 506.
6. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschöp MH. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl Acad. Sci. USA 2008 105 : 9793 9798.
7. Gedik E, Girgin S, Ozturk H, Obay BD, Ozturk H, Buyukbayram H. Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J. Gastroenterol. 2008 14 : 7101 7106.
8. Vitaglione P, Ottanelli B, Milani S, Morisco F, Caporaso N, Fogliano V. Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation. J. Gastroenterol. Hepatol. 2009 24 : 618 622.
9. Dolinsky VW, Chan AY, Robillard Frayne I et al. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation 2009 119 : 1643 1652.
10. Howitz KT, Bitterman KJ, Cohen HY et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 : 191 196.
11. Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2008 295 : G833 42.
12. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009 159 : 993 1002.
13. Leifert WR, Abeywarden MY. Cardioprotective actions of grape polyphenols. Nutr. Res. 2008 28 : 729 737.
14. Oberdoerffer P, Michan S, McVay M et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 2008 28 : 907 918.
15. Yildiz F, Terzi A, Halim C et al. Protective effects of resveratrol on small intestine against intestinal ischemia-reperfusion injury in rats. J. Gastroenterol. Hepatol. 2009 24 : 1781 1785.